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Abstract: Candida albicans infections range from superficial to systemic and are one of the leading
causes of fungus-associated nosocomial infections. The innate immune responses during these
various infection types differ, suggesting that the host environment plays a key role in modulating
the host–pathogen interaction. In addition, C. albicans is able to remodel its cell wall in response
to environmental conditions to evade host clearance mechanisms and establish infection in niches,
such as the oral and vaginal mucosa. Phagocytes play a key role in clearing C. albicans, which is
primarily mediated by Pathogen Associated Molecular Pattern (PAMP)–Pattern Recognition Receptor
(PRR) interactions. PRRs such as Dectin-1, DC-SIGN, and TLR2 and TLR4 interact with PAMPs such
as β-glucans, N-mannan and O-mannan, respectively, to trigger the activation of innate immune
cells. Innate immune cells exhibit distinct yet overlapping repertoires of PAMPs, resulting in the
preferential recognition of particular Candida morphotypes by them. The role of phagocytes in the
context of individual infection types also differs, with neutrophils playing a prominent role in
kidney infections, and dendritic cells playing a prominent role in skin infections. In this review,
we provide an overview of the key receptors involved in the detection of C. albicans and discuss
the differential innate immune responses to C. albicans seen in different infection types such as
vulvovaginal candidiasis (VVC) and oral candidiasis.
Keywords: Candida; cell wall; neutrophil; macrophage; candidiasis
1. Introduction
Candida albicans is both a commensal and opportunistic fungal pathogen of humans,
the delicate balance of which is maintained by the actions of the innate immune system
and resident microbiota. C. albicans is able to colonise most areas of the body, including
the nails, skin, mucosal membranes, and internal organs. The colonisation of the skin and
gastrointestinal tract is thought to occur at birth when the infant passes through the birth
canal, where C. albicans is a natural resident [1]. During periods of immune suppression,
such as in those with HIV, neutropenia, or dysbiosis of the microbiota, C. albicans can
overcome the innate immune system to establish various infections, such as superficial
mucosal infections (oral and genital thrush), subcutaneous infections and systemic dis-
ease (candidemia). Although mucosal infections are not life-threatening, they pose high
morbidity rates and are expensive to treat, while candidemia is associated with a poor
prognosis and high mortality (40–50%) [2]. C. albicans is armed with a plethora of viru-
lence factors including adhesins (i.e., Hwp1, Als3, and Als5), secreted hydrolytic enzymes
(i.e., SAPs and phospholipases) and the recently identified cytolytic toxin candidalysin [3,4].
C. albicans can also form biofilms in nail infections; on teeth exacerbating, tooth decay;
on mucosal surfaces; and on the surfaces of medical devices, including catheters, long lines
and voice prostheses [5,6]. This capacity to form biofilms has made C. albicans one of
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the leading causes of nosocomial infections, which are difficult to treat due to increasing
antifungal resistance.
Despite the causal agent being the same in each infection, the innate immune responses
elicited during these infections are very different, suggesting that the host environment
plays a key role in modulating the host–pathogen interaction. The majority of innate im-
mune responses are mediated by the interaction between Pattern Recognition Receptors
(PRRs) expressed on the surface of innate immune cells, and Pathogen Associated Molec-
ular Patterns (PAMPs) on the fungal surface. The Candida cell wall consists of an inner
skeletal layer of β-glucan and chitin, and an outer layer of glycosylated proteins [7,8].
These proteins play essential roles in adhesion to host cells, while carbohydrate PAMPs are
recognised by PRRs on the surface of innate immune cells. The main families of receptors
involved in the recognition of C. albicans are the C-type lectin receptors (CLRs), RIG I-like
receptors (RLRs), NOD-like receptors (NLRs) and Toll-like receptors (TLRs), which recog-
nise distinct PAMPs (Table 1). Each innate immune cell has a distinct, but overlapping,
repertoire of receptors, giving rise to its preferential recognition of certain morphotypes.
The response elicited against a microorganism is governed by the mosaic of receptor com-
plexes engaged. In this review, we provide an overview of the key receptors involved in the
detection of C. albicans, summarise the immune sensing of C. albicans occurring in different
infection types, and discuss the potential role the host environment plays in modulating
these responses.
Table 1. Pattern Recognition Receptors (PRRs) involved in the recognition of C. albicans.
Family PRR PAMP Expression References





Dectin-2 α-mannan Dendritic cell,macrophage [13,14]
Dectin-3 α-mannan Macrophage [15]
DC-SIGN N-mannan Dendritic cell [16,17]




N-mannan Dendritic cell,macrophage [17,19,20]















Galectins Galectin-3 β-mannosides Macrophage [10]
2. Recognition by Phagocytes
The successful clearance of C. albicans from the host tissue relies heavily upon the
phagocytosis of the fungal pathogen by innate immune cells (i.e., macrophages, neutrophils
and dendritic cells). Phagocytosis is a multi-step process initiated by pathogen recognition.
This leads to the engulfment of the pathogen, phagosome maturation to eliminate the
pathogen and then the resolution of the phagolysosome, and this has been extensively
reviewed by Levin et al. [26]. Innate immune cells interact differently with the yeast and
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hyphal morphologies of Candida [27]. This is partly due to the differential exposure of
β-glucan, with β-glucan exposure at yeast bud scars provoking Dectin-1-dependent proin-
flammatory innate immune responses [11]. Hyphae generally have less β-glucan exposed
on their cell surface and, therefore, are less effectively recognized by Dectin-1 [11]. However,
activated neutrophils can expose β-glucan in hyphal cells, leading to Dectin-1-dependent
recognition and proinflammatory cytokine secretion [28]. Furthermore, the hyphal orienta-
tion during contact with phagocytic cells also impacts phagocytosis, with macrophages
encountering hypha tips phagocytosing the Candida quicker [29]. Therefore, there are multi-
ple factors that contribute to how macrophages interact with Candida. Dendritic cells (DCs)
also discriminate between the different morphologies, and this differentially stimulates
adaptive immunity, with yeast cells provoking a Th1 response, while hyphae initiate a Th2
response [30].
Neutrophils are the major immune cells in the control of candidiasis, and thus, neu-
tropenic individuals and mice have an increased susceptibility to candidiasis [31–34].
The C-type lectin receptor Dectin-1 is the most important neutrophil PRR in C. albicans
recognition. The engagement of Dectin-1 leads to the activation of integrin Mac-1 (CR3),
and both receptors are essential for fungal engulfment and elimination [12]. Macrophages
also play a key role in phagocytosis and Candida clearance in various niches, while den-
dritic cells specialise in processing and presenting antigenic material from Candida to
lymphocytes, acting as a bridge between the innate and acquired immune systems [35].
Like neutrophils, these innate immune cells recognise C. albicans by its cell wall PAMPs;
β-1,3-glucan is recognised by the C-type lectin receptor Dectin-1 and complement receptor
3 (CR3); N-mannan, by Dectin-2, DC-SIGN and MINCLE; and O-mannan, by TLR4 (Table 1
and Figure 1) [14,36–39].
The recognition of these PAMPs initiates phagocytosis, which involves two main
stages: (i) phagosome formation and (ii) maturation. Phagosomes are formed when phago-
cytic receptors such as CR3, Fcγ receptors (FcγRs) and Dectin-1 bind to phagocytic targets
and result in receptor clustering. Subsequent to receptor clustering, the phosphorylation
of their immunoreceptor tyrosine-based activation motifs (ITAMs) and the activation of
Rho-family GTPases occur. Rho-GTPases activate nucleation-promoting factors (NPFs),
which cause actin-driven protrusions from the plasma membrane to advance around
the target [40,41]. The activation of myosin by cytosolic Ca2+ has been suggested to be
necessary in phagocytic cup formation and sealing, to form the phagosome [26,42].
Phagosome maturation is a gradual process whereby the phagosome is converted
into a hostile and degradative environment to achieve pathogen elimination. The process
differs between neutrophils and macrophages, which has been reviewed in detail [26,43].
Briefly, in neutrophils, phagosome maturation occurs rapidly and involves fusion with
lysosomes and neutrophil granules containing antimicrobial peptides and proteolytic
enzymes [43–45]. In macrophages, endosomal fusion begins early during phagosome mat-
uration and is driven by the recruitment of active Rab5 and then Rab7 as they transi-
tion into late phagosomes. Eventually, lysosomes fuse with late phagosomes to form
a phagolysosome, which is armed with lytic enzymes and is highly acidic (i.e., in M2
macrophages, which are involved in tissue repair and the resolution of inflammation) and
oxidative, to provide an extremely degradative environment for pathogens [26,46–48]. No-
tably, neutrophils and M1 macrophages (proinflammatory macrophages)—the cells mainly
responsible for pathogen elimination—maintain a slightly alkaline compartment during
this transition. These phenomena are attributed to the increased proton consumption dur-
ing superoxide dismutation, reduced granule fusion observed during reactive oxygen
species (ROS) production, and increased leakiness for H+ caused by the oxidative effect of
ROS [49,50]. The sustained alkalinization of the phagosomal compartment is also true for
dendritic cells. Dendritic cells prioritise antigen presentation and, therefore, must regulate
their phagosomal contents for partial degradation [51]. To achieve this, ROS production
is maintained at low levels for sustained periods by the recruitment of NADPH oxidase,
NOX2, to phagosomes shortly after phagocytosis [51].
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Figure 1. Key response pathways activated b innate immune cells against Candida albicans. Following successful recognition
of Candida PAMPs (such as O-mannan, α-mannan, N-mannan and β-glucans) by im u e cell PRRs (such as TLR2, TLR4,
Dectin-1 and DC-SIGN), im une c lls use a number of response mechanisms to eal with Candida inf ctions. These include
(I) engulfment and (II) elimination of the pathogen within the phagosome, where it encounters acidic pH and increased
reactive oxygen species (ROS) production; (III) cytokine release, aiding immune cell recruitment, and exerting direct
antimicrobial effects; (IV) entrapment and elimination of pathogens by releasing extracellular traps comprised of DNA with
antimicrobial agents; (V) antigen presentation, activating the adaptive immune system by presenting antigenic peptides to
T-cells on their major histocompatibility complex (MHC) molecules.
ROS generation is initiated by NADPH activation in neutrophils and potentiates
Candida killing within phagosomes [39,52,53]. In neutrophils, NADPH is produced by two
separate, glucose-dependent pathways: glycolysis and the pentose phosphate pathway [54].
Kidney patients with reduced expression of a glucose transporter, GLUT1, and patients
with chronic granulomatous disease have increased susceptibility to candidiasis, exempli-
fying the importance of NADPH oxidase [55]. In macrophages, the engagement of Dectin-1
causes the phosphorylation of the ITAM-like motif in its cytoplasmic tail. This leads to
the subsequent recruitment of the tyrosine kinase, Syk, and the activation of NF-
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stress on the phagosome and may lead to phagosomal rupture, although other factors
such as candidalysin release have also been implicated in phagosomal rupture and es-
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the recognition and engulfment of Candida. These lysosomes are increasingly fused to the
phagolysosomes to increase their surface area as the hyphae cause the distention of the
phagolysosomal membrane, causing transient releases of Ca2+ into the cytosol. This ensures
Candida remains confined within intact phagolysosomes long enough to effect killing [60].
The recognition of Candida by macrophages, neutrophils and dendritic cells, alike,
results in the release of inflammatory and chemotactic cytokines, aiding further immune cell
recruitment and infection resolution (Figure 1). Candida exposure results in the macrophage
release of proinflammatory cytokines such as TNF-α, IL-1β and IL-6, enhancing Candida
clearance and neutrophil recruitment [61–64]. Neutrophils play a key role in Candida
clearance, by releasing proinflammatory cytokines such as TNF-α and IL-12, through the
formation of neutrophil extracellular traps (NETs) and enhance dendritic cell recruitment
and activation [65]. The release of IL-6 and IL-23 by dendritic cells augments the Thelper
cell response to Candida infection, including the key Th17 response [66] (Figure 1).
3. Niche-Specific Immune Sensing of C. albicans
3.1. Skin and Nail Infections
Warm and moist environments promote the expansion of C. albicans on the skin,
leading to superficial skin infections, such as nappy rash, athlete’s foot and nail infections.
C. albicans uses hydrolytic enzymes, such as secreted aspartic proteinases, shown to be
important in tissue invasion and believed to be involved in establishing nail and other
superficial infections [67–69]. Such infections are potentiated by increased phospholipase
activity, which also correlates with biofilm formation, particularly in nail infections [67,69].
Although little is known about immune sensing in the skin and nails, the presence of DCs
in the skin suggests their involvement in C. albicans sensing and the immune response in
this context. Skin-derived DCs from foetal mouse skin phagocytose both yeast and hyphal
forms of Candida [30]. The phagocytosis of the different morphotypes induces differential
cytokine profiles, influencing the T-helper activation pathways. Yeast cells induce the
production of IL-12 and activation of the protective Th1 pathway, while hyphae induce IL-4
production and Th2 activation [30,35]. Furthermore, the activation of the Th17 pathway in
the skin requires the secretion of IL-1β and IL-6 [70]. This illustrates the discriminatory
ability of DCs in sensing and responding to the different morphotypes of Candida (Table 2).
Table 2. Summary of immune sensing and responses at different infection sites.
Infection Type Immune Sensing of Candida albicans Inflammatory Response References
Nail and Skin
Infection Dendritic cells IL-12, IL-4, IL-1β, IL-6 [30,35,70]
Oral Candidiasis
Oral epithelial cells IL-1α/β, IL-8, G(M)-CSF, CCL20,CXCL2, β-defensins, S100A8/9 [71,72]
Neutrophils IL-1β, NET formation [73]
ILC3 IL-17A/F [74]
γδ T-cells IL-17A/F [75]
Natural Th17 cells IL-17A/F [76–78]
Vaginal Candidiasis
Vaginal epithelial cells IL-1β, S100A8 alarmin [79,80]
Neutrophils NET formation [73]
Candidemia
Neutrophils ROS and NET formation, JAGN1 [73,81]
Platelets IL-8, platelet microbicidal protein [82,83]
3.2. Oral Candidiasis
C. albicans is a commensal of the oral mucosa, but during periods of immune sup-
pression, the balance between commensalism and pathogenesis is lost, leading to Candida
overgrowth and infection. These infections are commonly associated with biofilm for-
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mation, especially in patients with dentures, voice protheses and xerostomia (reduced or
absent saliva flow). Biofilm formation makes these infections difficult to treat because
they are generally polymicrobial in nature, and the production of extracellular matrix
increases the resistance to antimicrobial therapy [5,6,84]. Oral candidiasis is prevalent in
immunosuppressed individuals such as HIV patients, mouth and throat cancer patients,
and patients taking oral steroids making them highly susceptible to infection. Although
the surveillance for oral candidiasis is limited, it is estimated that 20–50% of HIV patients
develop oral candidiasis [85,86]. The prevalence of oral candidiasis in HIV/AIDS patients
suggests that CD4+ cells play an essential role in combating oral colonisation, which is in
contrast to the case for other Candida infections.
The immune sensing of Candida at the oral mucosa is initiated by the oral epithelial
cells, by a biphasic MAPK response, which has been extensively reviewed elsewhere [87–90].
Briefly, low levels of Candida colonisation on the oral mucosa activate NF-
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signalling,
Pi3K signalling and the three major MAPK pathways (p38, JNK and ERK1/2), through
the recognition of components of the fungal cell wall (i.e., β-glucan and mannans) by
traditional PRRs (i.e., TLR2, TLR4, EphA2 and Dectin-1) [91–93] as outlined in Table 1.
However, this low-level activation does not result in a significant proinflammatory innate
immune response, indicating that the recognition of cell wall PAMPs is not sufficient to
fully activate oral epithelial cells. Instead, the induction of mucosal immunity requires
the overgrowth of Candida on the oral mucosa coupled with hyphal formation. This i -
crease in fungal burden on the oral mucosa activates the second MAPK response involving
MEK1/2-ERK1/2, leading to the activation of c-Fos and MPK1—the “danger response”
(Figure 2, Table 2). This strong activation of MAPK signalling results in the production
of antimicrobial peptides, the secretion of proinflammatory cytokines, and subsequent
phagocyte recruitment [91]. The activation of this second MAPK response is dependent
on the secretion of the peptide toxin candidalysin [3,94], suggesting that epithelial cells
primarily respond to damage rather than traditional PAMP–PRR interactions.
The recruited macrophages and neutrophils function to clear C. albicans through
PAMP–PRR-directed phagocytosis, as detailed above, with NETs killing large hyphal
cells that cannot be phagocytosed [95]. The subsequent production of TNF-α by phago-
cytes results in increased TLR4 expression on the epithelial cell surface, which confers
mucosal protection [71]. In addition to the recruitment of phagocytes, the candidalysin-
dependent activation of epithelial cells also recruits lymphoid cell type 3 (ILC3), γδ T-cells
and natural Th17 cells, which are activated by IL-1β secreted by neutrophils and epithe-
lial cells [74–76,96,97]. The activation of these cells results in the production of IL-17A
and IL-17F, which potentiates the epithelial response by further inducing the secretion of
proinflammatory cytokines, histatins and β-defensins from the epithelial cells and salivary
glands [72,77,78,98,99] (Table 2). As a result, individuals with defective IL-17 signalling are
highly susceptible to oral candidiasis, highlighting the importance of IL-17 in oral mucosal
immunity to Candida [100,101].
3.3. Vaginal Candidiasis
Vaginal candidiasis (VVC) is one of the most common Candida infections, infecting
75% of the female population, with up to 10–15% developing recurrent infections (RVVC),
defined as three or more episodes in a twelve-month period [102,103]. Unlike for oral can-
didiasis, immune suppression is not a prerequisite for infection, and HIV-positive women
are not more prone to the development of VVC. Instead, the predisposing factors include
vaginal dysbiosis after antimicrobial therapy, elevated oestrogen levels (as a result of preg-
nancy, oral contraceptive use, or hormone-replacement therapy) and uncontrolled diabetes,
and some single-nucleotide polymorphisms are enriched in women with RVVC [104–109].
Although it is a mucosal infection, the innate immune response in VVC is different to that
in oral candidiasis, with IL-17 playing a minimal role [110–112].
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different sites as indicated in the boxes. This leads to immun cell re rui ment to the mucosa. While this leads to the effective
phagocytosis of Candida yeast and NET release to contain and kill hyphae in oral candidiasis, neutrophil recruitment causes
the aggravation of disease in vulvovaginal candidiasis (VVC). In VVC, neutrophil phagocytosis is impaired, and this is
partly due to reduced complement binding to Candida. This culminates in increased cytokine release, causing heightened
nonprotective inflammation. In contrast to in VVC, innate lymphoid cells, γδ cells and natural killer cells play a vital role in
Candida control by producing IL-17, known to potentiate the proinflammatory response of epithelial cells.
Symptomatic vaginal infections are characterised by a nonprotective proinflammatory
innate immune response, mediated by the influx of neutrophils, which has been reviewed
in detail [113–115]. To summarise, the interaction of C. albicans with vaginal epithelial
c lls results in the pr duction of IL-1β and S100A8 alarmin, which are potent neutrophil
chemoattractants and function to recruit n utrophils to the vaginal epithelium [79,80,116]
(Figure 2, Table 2). Neutrophil recruitment and, therefore, symptomatic dise se are depen-
dent on the pr duction of candidalysin, with strains defective in ca dida ysin maintaining
high levels f asymptoma c colonisation [94,117]. However, unlike in oral candidiasis,
where neutrophils are efficient a phagocyt sing yeast and trapping hyphae by NET re-
lease, these recruited neutrophils re unable to phagocytose and clear the fungal pathogen,
l ading to heightened nonprotect ve proinflammatory response [79, 18]. The neutrophil
dysfunction in VVC and RVVC has been linked to the inability of complement receptor 3
(CR3) to interact with the fungal cell wall protein, Pra1 [119]. Under normal circumsta ces,
the interaction of CR3 with Pra1 results in t formati f NETs and efficient killing of
fungal hyphae [73]. However, this interactio is inhibited in vaginal fluid due to hep-
aran sulphate, which competitively binds with CR3, preventing its interaction with Pra1,
and promotes Candida survival and symptomatic infection (Figure 2) [115,120]. Heparan
sulphate is induced by oestrogen, suggesting that women with high circulatory levels of
oestrogen are more prone to sympto atic infection due to higher vaginal mucosal levels of
heparin sulphate [121].
J. Fungi 2021, 7, 119 8 of 16
In addition to the role of host factors, C. albicans has been shown to remodel its cell
wall in response to specific environmental cues encountered at the vaginal mucosa [122].
The growth of C. albicans in lactate—the predominant carbon source at the vaginal mucosa
due to the presence of lactobacilli—promotes the concealment of β-glucans, reducing
innate immune recognition and, therefore, possibly contributing to the reduced neutrophil
phagocytosis rates [123,124]. On the other hand, acidic environments promote β-glucan
exposure, leading to the hyperactivation of innate immune responses and significant neu-
trophil influx [125]. These acid-adapted fungal cells are more resistant to neutrophil killing
and could also potentiate proinflammatory innate immune responses during VVC [126].
Analysis of the fungal cell wall from cells isolated from VVC patients identified β-glucan
exposure on hyphae [127]. Neutrophils have been shown to expose β-glucan during NETo-
sis, which is proposed to be the cause of glucan exposure on hyphae isolated from VVC
patients, but given that neutrophils are defective in fungal killing at the vaginal mucosa,
this remains to be confirmed [28,127].
3.4. Candidemia
In systemic infection, Candida enters the bloodstream and disseminates throughout
the body. The presence of Candida in the blood is known as candidemia, the most common
form of invasive candidiasis [128]. Candidemia can result in sepsis, infective endocarditis
and vascular thrombosis, with often fatal outcomes [82]. In healthy individuals, C. albicans
is rapidly removed from the bloodstream by the actions of neutrophils. Neutrophils are the
most abundant leukocyte in the bloodstream, and whilst they are not essential in protection
against other fungal pathogens such as Cryptococcus, neutropenic patients are more sus-
ceptible to systemic candidiasis. The chemokine receptor CXCR1 is essential in neutrophil
granulogenesis, degranulation and non-oxidative killing of C. albicans, alongside the en-
doplasmic reticulum transmembrane protein Jagunal homolog 1 (JAGN1) [81]. The most
infected organ in systemic candidiasis is the kidney, and neutrophils play a crucial role in
host immunity to Candida [129]. In mice lacking the chemokine receptor CCR1, neutrophil
accumulation in the infected kidney is impaired and delayed [130]. Interestingly, ccr1−/−
mice display higher survival rates and lower kidney tissue damage, and ccr1+/+ mice appear
to succumb to uncontrolled tissue damage due to excessive neutrophil recruitment and
activity, suggesting that the neutrophil CCR1 receptor mediates neutrophil tissue injury in
invasive candidiasis [130]. Conversely, the absence of the chemokine receptor CXCR1 is
associated with increased mortality and higher kidney fungal burden [131]. Neutrophil
recruitment was not affected in cxcr1−/− mice, but the neutrophils displayed impaired
degranulation and capacity to kill Candida [131].
The role of platelets in the innate immune response to Candida is often overlooked.
Although traditionally described as playing a key role in maintaining haemostasis, throm-
bosis and inflammation, platelets have more recently been recognised as key players of
the innate immune response to infection [132]. Whilst nonphagocytic, platelets have been
shown to interact with and be activated by bacteria, viruses and fungi, leading to the
release of various platelet antimicrobial peptides [133–137]. Thrombocytopenia is a known
risk factor for invasive fungal infections, including candidiasis [136]. The Candida–platelet
interaction is poorly understood and controversial, with the role of thrombosis in candidia-
sis yet to be determined. Several studies have shown that Candida species can bind and
induce the activation of platelets in vitro, although the degree of this activation is strain
and species specific [82,136]. Of those Candida species that can induce platelet aggrega-
tion, only small subpopulations of platelets have been shown to directly interact with
Candida [136]. Additional studies have suggested that C. albicans might inhibit platelet
aggregation through the production of gliotoxin, a fungal secondary metabolite, similar
to Aspergillus [138]. However, the production of gliotoxin by Candida species has been
debated [139]. The associated risk of candidiasis with thrombocytopenia highlights the
importance of platelets as immune regulators in bloodstream Candida infection. How-
ever, current studies suggest that the Candida–platelet interaction is complex, and likely
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dependent on the platelet donor and fungal strain under investigation. Understanding
the underlying mechanisms of the Candida–platelet interaction and the subsequent clinical
outcomes surrounding the interaction could prove fruitful for developing novel antifungal
therapies based on anticoagulants.
In order to reach internal organs, Candida must cross the endothelium lining the
blood vessels. To achieve this, Candida adheres to and transmigrates across endothelial
cells. C. albicans express an array of adhesins that facilitate adherence to endothelial cells,
such as αMβ2-like adhesin, which interacts with endothelial ICAM-1 and -2; αvβ3-like
adhesin, which interacts with PECAM-1; and agglutinin-like protein 3, which interacts
with N-cadherin [140]. The transmigration of C. albicans across endothelial cells is required
for Candida to exit the bloodstream and enter the tissue. There are various models for
how Candida transmigrates across endothelial cells. One model is that transmigration is
facilitated by the endothelial endocytosis of Candida, mediated by the endothelial cell
receptor N-cadherin [141]. Phan et al. showed that C. albicans hyphae bind to N-cadherin
with greater affinity than yeast, and human CHO cells expressing N-cadherin endocytose
significantly more C. albicans hyphae than CHO cells without cadherin expression [141].
C. albicans strains with homozygous null mutations in genes integral to filamentation
regulation, such as EFG1, TUP1 and CLA4, display impaired capacity to invade and
damage endothelial cells [142]. Furthermore, the ∆tup1 mutant produced pseudohyphae on
endothelial cells and displayed lower endothelial cell invasion and injury compared to the
∆cla4 mutants, which were aberrantly shaped but produced hyphae, collectively suggesting
that the formation of true hyphae is required for endothelial invasion and damage [142].
Conversely, Shintaku et al. [143] showed that like that of C. albicans, the internalisation of
Candida parapsilosis yeast cells is facilitated by N-WASP activation. However, N-cadherin
does not appear to play a role in C. parapsilosis internalisation [143]. Whilst most Candida–
endothelial cell interactions have been studied in vitro, there are also a few in vivo studies
investigating the mechanism(s) underlying Candida adhesion to, and transmigration across,
the endothelial lining of blood vessels. However, our current understanding of Candida–
endothelial cell interactions must be validated in vivo and would benefit from the inclusion
of other physical parameters including blood flow, which likely has an impact on the
Candida–endothelial interaction.
4. Summary
Candidiasis encompasses a range of infections, such as low-mortality-associated
infections such as oral thrush, and fatal infections such as candidemia. The ability of Candida
to establish disease in host niche environments and our understanding of the mechanisms
underpinning this are paramount in our bid to tackle candidiasis. The ability of the host
immune cells—namely, but not solely, phagocytic cells—to identify and destroy Candida is
key in our understanding of how the pathogenic fungus is able to evade immune clearance.
Research on the interplay between Candida and phagocytic cells, such as macrophages and
neutrophils, has alluded to the various PAMPs and PRRs involved in Candida detection.
CLRs, such as Dectin-1 and DC-SIGN; TLRs, such as TLR2 and TLR4; and other receptors
such as Galectin-3 and CR3 have all been shown to play a role in Candida infection. Likewise,
corresponding PAMPs implicated in Candida–host interaction have also been identified,
such as β-glucan and O-mannan. Whilst much has been done to identify which PAMPs
and PRRs are involved in host–Candida interplay, there is much research to be conducted
on the roles of these, and the subsequent activation pathways implicated in Candida
engulfment and destruction, under the niche host conditions where Candida establishes
itself. For example, under normal conditions, neutrophils are able to recognise, engulf
and destroy Candida via the receptors CR3 and FcγR, and NADPH oxidase activity [144].
In VVC, however, there is significant neutrophil recruitment, but these neutrophils are
unable to control the infection, and several environmental factors, including the heparan-
sulphate-dependent inhibition of CR3 recognition and reduced Dectin-1 recognition due to
lactate inducing β-glucan masking, have been suggested to account for this nonprotective
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innate immune response. Therefore, Candida appears to have a remarkable capacity to
adapt to the host environment and subsequently evade clearance by the immune system.
The key to developing therapeutics against candidiasis lies in our understanding of how
Candida does this, and how it affects its interaction with immune cells and subsequent
immune cell activity.
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